This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Abstract Background: The association between vitamin D-binding protein (VDBP) and 25-hydroxyvitamin D (25 (OH)D) with colorectal cancer (CRC) is still ambiguous. This study was to further investigate the relationship between serum VDBP, 25 (OH)D levels and the clinical and pathological features of patients with CRC.Methods: Enzyme-linked immunosorbent assay (ELISA) and chemiluminescence immunoassay were used to analyze the VDBP and 25(OH)D concentrations in serum.Pearson's correlation analysis was applied to evaluate the association between serum VDBP and 25(OH)D levels in CRC. Conditional logistic regression was performed to analyze the prediction value of serum VDBP or 25(OH)D as a risk factor for CRC.
Results:The serological levels of 25(OH)D in patients were significantly lower than in healthy individuals, while VDBP levels were significantly higher than in healthy controls. The serum VDBP in pre-operative was significantly lower than in post-operative samples, while the serum 25(OH)D from pre-operative patients was significantly higher than post-operative patients. Patients with tumors with higher stage and increased lymph node involvement had lower serum post-operative VDBP levels. In addition, our results showed that the pre-operative VDBP level is a risk factor of CRC.
Conclusions:The levels of serum 25(OH)D and VDBP were both associated with CRC.Thus, serum 25(OH)D and VDBP levels might be of value in evaluating the pathogenesis and risk of CRC in the future. Moreover, serum VDBP or 25(OH)D levels were associated with patient's clinical and pathological features providing data for risk and prognostic prediction.Colorectal cancer (CRC) is a common type of cancer worldwide. 1 In China, the estimated new cases and deaths of CRC were 376 300 and 191 000, respectively, in 2015. 2 Benefited by the development of screening tools for early detection, more and more patients could be treated at an early stage; however, the incidence and mortality of CRC among adults aged under 50 years is increasing in the United States. 3Accumulating evidence indicates that high levels of circulating vitamin D is an anti-cancer factor, which may reduce the risk of CRC. [4][5][6] Vitamin D (VD) is photochemically synthesized in the skin when exposed to ultraviolet B (UVB) radiation or ingested from food and/ or supplements. Once getting into blood circulation, VD is hydroxylated and forms 25-hydroxyvitamin D [25(OH)D] in the liver, the well-known biomarker of VD status. Then, 25(OH)D is hydroxylated and forms 1,25-dihydroxyvitamin D [1,25(OH)2D] in the kidney and other organs, the bioactive form of VD. 7 Recent studies found that free 25(OH)D may be an independent CRC prognostic biomarker. 8 Vitamin D-binding protein (VDBP), primarily vitamin D carrier ...